Is Relapse-Free Survival at 2-Years an Appropriate Surrogate for Overall Survival at 5-Years in EGFR-mutated Resected NSCLC?

被引：0
|
作者：
Garcia, M. [1 ]
Schmid, S. [1 ]
Hueniken, K. [1 ]
Zhan, L. [1 ]
Balaratnam, K. [1 ]
Khan, K. [1 ]
Fares, A. [2 ]
Chan, S. [1 ]
Smith, E. [1 ]
Aggarwal, R. [1 ]
Brown, M. C. [1 ]
Patel, D. [1 ]
Sacher, A. [1 ]
Bradbury, P. [1 ]
Shepherd, F. A. [1 ]
Leighl, N. [1 ]
Liu, G. [1 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON, Canada
[2] Famerp, Ctr Oncol Hosp Base, Sao Jose Do Rio Preto, SP, Brazil
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
NSCLC; EGFR;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P48.05
引用
收藏
页码：S1107 / S1108
页数：2
相关论文
共 50 条
  • [31] Delay in initiation of adjuvant trastuzumab therapy leads to decreased overall survival and relapse-free survival in patients with HER2-positive non-metastatic breast cancer
    Gallagher, Christopher M.
    More, Kenneth
    Kamath, Tripthi
    Masaquel, Anthony
    Guerin, Annie
    Ionescu-Ittu, Raluca
    Gauthier-Loiselle, Marjolaine
    Nitulescu, Roy
    Sicignano, Nicholas
    Butts, Elizabeth
    Wu, Eric Q.
    Barnett, Brian
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (01) : 145 - 156
  • [32] Improved Relapse-Free Survival and Overall Survival in Patients with High Immune Reconstitution of Gamma Delta T Cells 2 Months after Allogeneic Hematopoietic Stem Cell Transplantation
    Minculescu, Lia
    Marquart, Hanne Vibeke
    Ryder, Lars Peter
    Schjodt, Ida
    Friis, Lone Smidstrup
    Kornblit, Brian Thomas
    Petersen, Soren Lykke
    Andersen, Niels Smedegaard
    Hastrup, Eva Kannik
    Fischer-Nielsen, Anne
    Sengeloev, Henrik
    BLOOD, 2018, 132
  • [33] Predictive factors involved in determining response to neoadjuvant chemotherapy in breast cancer and impact of response on 5 years disease free survival and overall survival
    Rehman, B.
    Parvaiz, M. A.
    EUROPEAN JOURNAL OF CANCER, 2020, 138 : S40 - S40
  • [34] Disease-Free Survival at 2 or 3 Years Correlates With 5-Year Overall Survival of Patients Undergoing Radical Cystectomy for Muscle Invasive Bladder Cancer
    Sonpavde, Guru
    Khan, Myrna M.
    Lerner, Seth P.
    Svatek, Robert S.
    Novara, Giacomo
    Karakiewicz, Pierre I.
    Skinner, Eila
    Tilki, Derya
    Kassouf, Wassim
    Fradet, Yves
    Dinney, Colin P.
    Fritsche, Hans-Martin
    Izawa, Jonathan I.
    Bastian, Patrick J.
    Ficarra, Vincenzo
    Schoenberg, Mark
    Sagalowsky, Arthur I.
    Lotan, Yair
    Shariat, Shahrokh F.
    JOURNAL OF UROLOGY, 2011, 185 (02): : 456 - 461
  • [35] IMPACT OF TYROSINE KINASE INHIBITOR (TKI) DOSAGE MODIFICATIONS ON PROGRESSION-FREE SURVIVAL (PFS) IN THE TREATMENT OF EGFR-MUTATED NON-SMALL CELL LUNG CANCER (NSCLC)
    Carrasquilla, S.
    Bi, Y.
    Gu, W.
    Ayyoub, A.
    Fletcher, E. Pfuma
    Liu, J.
    Ramamoorthy, A.
    Shord, S.
    Zineh, I.
    Madabushi, R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 : S21 - S21
  • [36] 5-years relapse-free survival and predictive factors identification in HR-positive HER2-negative breast cancer patients treated with anastrozole or fulvestrant neoadjuvant endocrine therapy: Pooled analysis of the CARMINA02 and HORGEN phase II trials
    Lerebours, F.
    Pulido, M.
    Fourme, E.
    Debled, M.
    Becette, V.
    Bonnefoi, H.
    Rivera, S.
    Mac Grogan, G.
    Mouret-Reynier, M. A.
    de Lara, C. Tunon
    Pierga, J. Y.
    Breton-Callu, C.
    Venat-Bouvet, L.
    Mathoulin-Pelissier, S.
    Kerbrat, P.
    Dalenc, F.
    Sigal, B.
    Bachelot, T.
    Lemonnier, J.
    Lerebours
    Quenel-Tueux, N.
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : S19 - S19
  • [37] Single Nucleotide Polymorphisms of Integrin Alpha-2 and Beta-3 Genes Are not Associated with Relapse-free and Overall Survival in Colorectal Cancer Patients
    Hofmann, Guenter
    Langsenlehner, Uwe
    Langsenlehner, Tanja
    Glehr, Matthias
    Gerger, Armin
    Absenger, Gudrun
    Szkandera, Joanna
    Fuerst, Florentine
    Samonigg, Hellmut
    Krippl, Peter
    Renner, Wilfried
    ANTICANCER RESEARCH, 2011, 31 (04) : 1373 - 1377
  • [38] HDR-Like Prostate Stereotactic Body Radiotherapy: Evaluation of PSA kinetics, Clinical Relapse-free Survival and Adverse Events Beyond 5 years in a Multi-institutional Study
    Fuller, D. B.
    Kane, B. L.
    Crabtree, T.
    Medbery, C. A., III
    Underhill, K., Jr.
    Gray, J. R.
    Peddada, A. V.
    Chen, R. C.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : S133 - S133
  • [39] Overall Survival Benefits of First-Line Treatments for Asian Patients With Advanced EGFR-Mutated NSCLC Harboring L858R Mutation: A Systematic Review and Network Meta-Analysis
    Chan, Sik-Kwan
    Choi, Horace Cheuk-Wai
    Lee, Victor Ho -Fun
    JTO CLINICAL AND RESEARCH REPORTS, 2022, 3 (05):
  • [40] Minimal Extrathyroid Extension Does Not Affect the Relapse-Free Survival of Patients with Papillary Thyroid Carcinoma Measuring 4 cm or Less over the Age of 45 Years
    Yasuhiro Ito
    Chisato Tomoda
    Takashi Uruno
    Yuuki Takamura
    Akihiro Miya
    Kaoru Kobayashi
    Fumio Matsuzuka
    Kanji Kuma
    Akira Miyauchi
    Surgery Today, 2006, 36 : 12 - 18
12345